Programme, 9 May 2007

European Conference on Colon Cancer Prevention 2007
- Status Quo and Perspectives
Date:
9 May 2007
Venue:
Building of the Bavarian Representation in Brussels (formerly the Institute Pasteur)
Programme Outline:
DOWNLOAD the programme.
7.30 am - 8.30 am
8.30 am - 9.00 am
Karolina Gernbauer
Assistant Secretary of State and Head of the Bavarian EU Representation in Brussels
Christa Maar
CEO Felix Burda Foundation and President of the German Network against Colon Cancer, Germany
9.00 am - 10.30 am
Chairmen:
Colm ÓMoráin, Ireland
Eric Van Cutsem, Belgium
Participants:
Massimo Crespi, Italy
Colon cancer: A pan-European health issue of increasing urgency The Epidemiology of colon cancer in European countries
Jaroslaw Waligóra, European Commission, Luxembourg
A European cancer screening policy What does it serve and which programmes does it support?
Jean Faivre, France
Evidence, efficacy and efficiency of stool and serum tests
Hermann Brenner, Germany
Evidence, efficacy and efficiency of endoscopic screening methods
10.30 am - 11.00 am
11.00 am - 12.30 pm
Chairmen:
Jean Faivre, France
Wolff Schmiegel, Germany
Participants:
Meinhard Classen, Germany
The status quo of colon cancer screening in Europe A pan-European survey about
screening and the application of existing guidelines in diagnostic procedures
Nea Malila, Finland
Screening practice in Finland
Miroslav Zavoral, Czech Republic
Screening practice in Czech Republic
Nereo Segnan, Italy
Screening practice in Italy
Wolff Schmiegel, Germany
Screening practice in Germany
12.30 pm - 1.30 pm
1.30 pm - 3.45 pm
Chairmen:
Geir Hoff, Norway
Hermann Brenner, Germany
Participants:
Robert J.C. Steele, United Kingdom
Increasing public acceptance for colon cancer screening programmes through invitation schemes
Christa Maar, Germany
Increasing public acceptance for colon cancer screening programmes through public relation campaigns and the establishment of dedicated networks
Ernst J. Kuipers, The Netherlands
Which colon cancer screening programmes can we afford? A cost-benefit analysis of different approaches
Hans F.A. Vasen, The Netherlands
Can the identification of high-risk groups increase the effectiveness of colon cancer screening programmes?
Bernhard Gibis, Germany
Colorectal cancer screening programmes conducted through gFOBT must be quality-assured in terms of structures, execution and evaluation
Berndt Birkner, Germany
Quality-assurance of screening colonoscopy
Monika Sieverding, Germany
Correlates of colorectal cancer screening in men and women in Germany
3.45 pm - 4.15 pm
4.15 pm - 6.00 pm
Chairmen:
Meinhard Classen, Germany
Guido Tytgat, The Netherlands
Participants:
Geir Hoff, Norway
Jaroslaw Regula, Poland
Gerhard Brenner, Germany
Colm ÓMoráin, Ireland